AI model to predict survival factors in lung cancer for better trial recruitment - OutSourcing-Pharma.com

AI model to predict survival factors in lung cancer for better trial recruitment  OutSourcing-Pharma.com

Concerto HealthAI launches model to predict survival rates in lung cancer patients in an aim to garner disease insights that could improve enrollment criteria.



Comments

Popular posts from this blog

Stage 4 Lung Cancer Life Expectancy

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

Free biotech stocks directory, pharma stocks, telemedicine stocks ...